Nintedanib & Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF) in King Abdulaziz Medical City (KAMC), Riyadh - Real Life Data

被引：0
|
作者：
Khan, A. M. [1 ]
Al-Jahdali, H. H. [2 ]
Alharbi, A. S. [3 ]
Rajendram, R. [1 ]
Obaidi, M. [1 ]
Alghamdi, B. [1 ]
Hassan, I. [1 ]
机构：
[1] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Pulmonol Div, Med, Riyadh, Saudi Arabia
[2] King Fahad Natl Guard Hosp, Riyadh, Saudi Arabia
[3] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Pulmonolgy, Med, Riyadh, Saudi Arabia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1917
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort
    Durheim, Michael T.
    Bendstrup, Elisabeth
    Carlson, Lisa
    Sutinen, Eva M.
    Hyldgaard, Charlotte
    Kalafatis, Dimitrios
    Myllarniemi, Marjukka
    Skold, C. Magnus
    Sjaheim, Tone
    RESPIROLOGY, 2021, 26 (10) : 982 - 988
  • [42] Safety Of The Combined Use Of Pirfenidone And Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From An Interim Analysis After 12 Weeks
    Flaherty, K. R.
    Sussman, R.
    Pesci, A.
    Nunes, H.
    Acosta, O.
    Petzinger, U.
    Stauffer, J.
    Gilberg, F.
    Bengus, M.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience
    Pianigiani, Lucrezia
    Fui, Annalisa
    Cameli, Paolo
    Carobene, Loredana
    Refini, Rosa Metella
    Pieroni, Maria
    Fossi, Antonella
    Bennett, David
    Rottoli, Paola
    Valentini, Maria Lucia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [44] Effectiveness of pirfenidone in idiopathic pulmonary fibrosis: results from a real-life study
    Rivano, M.
    Uda, M. E.
    Corda, G. M.
    Vacca, V.
    Aledda, L.
    Deidda, S.
    Zucca, C.
    Lombardo, F.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1551 - 1552
  • [45] Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
    Vietri, Lucia
    Cameli, Paolo
    Perruzza, Marco
    Cekorja, Behar
    Bergantini, Laura
    D'Alessandro, Miriana
    Refini, Rosa Metella
    Pieroni, Maria
    Fossi, Antonella
    Bennett, David
    Spalletti, Marco
    Mazzei, Maria Antonietta
    Sestini, Piersante
    Rottoli, Paola
    Bargagli, Elena
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [46] A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis
    Harari, Sergio
    Caminati, Antonella
    Poletti, Venerino
    Confalonieri, Marco
    Gasparini, Stefano
    Lacedonia, Donato
    Luppi, Fabrizio
    Pesci, Alberto
    Sebastiani, Alfredo
    Spagnolo, Paolo
    Vancheri, Carlo
    Balestro, Elisabetta
    Bonifazi, Martina
    Cerri, Stefania
    De Giacomi, Federica
    Della Porta, Rossana
    Barbaro, Maria Pia Foschino
    Fui, Annalisa
    Pasquinelli, Patrizio
    Rosso, Roberta
    Tomassetti, Sara
    Specchia, Claudia
    Rottoli, Paola
    RESPIRATION, 2018, 95 (06) : 433 - 440
  • [47] SAFETY OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A REAL-LIFE STUDY AT OUR HOSPITAL
    Okamoto, Mariko
    Saji, Junko
    Kanno, Yuki
    Tsunoda, Akihito
    Komatsubara, Yuka
    Onoe, Rintaro
    Furuya, Naoki
    Inoue, Takeo
    Miyazawa, Teruomi
    Mineshita, Masamichi
    RESPIROLOGY, 2018, 23 : 160 - 161
  • [48] Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis
    Santoleri, Fiorenzo
    Auriemma, Luigia
    Spacone, Antonella
    Marinari, Stefano
    Esposito, Fabio
    De Vita, Francesco
    Petragnani, Giovanni
    Di Fabio, Caterina
    Di Fabio, Letizia
    Costantini, Alberto
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (06) : 853 - 858
  • [49] Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
    Cameli, Paolo
    Refini, Rosa Metella
    Bergantini, Laura
    d'Alessandro, Miriana
    Alonzi, Valerio
    Magnoni, Carlo
    Rottoli, Paola
    Sestini, Piersante
    Bargagli, Elena
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [50] Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
    Lee, Eung Gu
    Lee, Tae-Hee
    Hong, Yujin
    Ryoo, Jiwon
    Heo, Jung Won
    Kang, Hye Seon
    Kwon, Soon Seog
    Kim, Yong Hyun
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345